Figure 2
From: The role of PD-L1 in the radiation response and clinical outcome for bladder cancer
Effect of irradiation on PD-L1 expression in human bladder cancer.
The levels of PD-L1 were evaluated by (a) FACS and (b) IF staining with the PD-L1 antibody for human bladder cancer cells and (c,d) for murine bladder cancer cells at the indicated times after 6 Gy irradiation or at 48 h after RT with 0, 3, 6 and 9 Gy in vitro. Representative slides are shown.
